123 related articles for article (PubMed ID: 1459738)
1. Analysis of two human monoclonal antibodies against melanoma.
Yeilding NM; Gerstner C; Kirkwood JM
Int J Cancer; 1992 Dec; 52(6):967-73. PubMed ID: 1459738
[TBL] [Abstract][Full Text] [Related]
2. Human IgG and IgM monoclonal antibodies against autologous melanoma produced by Epstein-Barr-virus-transformed B lymphocytes.
Kirkwood JM; Robinson JE
Cancer Immunol Immunother; 1990; 32(4):228-34. PubMed ID: 2175672
[TBL] [Abstract][Full Text] [Related]
3. In vitro production of human antibodies specifically reactive with human gastric cancer cells of established lines and autologous tissues.
Takayama T; Sakabe T; Fujii M; Yamada E; Uno M; Ono Y
J Surg Oncol; 1987 Nov; 36(3):215-24. PubMed ID: 2824934
[TBL] [Abstract][Full Text] [Related]
4. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.
Anichini A; Maccalli C; Mortarini R; Salvi S; Mazzocchi A; Squarcina P; Herlyn M; Parmiani G
J Exp Med; 1993 Apr; 177(4):989-98. PubMed ID: 8459226
[TBL] [Abstract][Full Text] [Related]
5. A human monoclonal antimelanoma single-chain Fv antibody derived from tumor-infiltrating lymphocytes.
Zhang H; Lake DF; Barbuto JA; Bernstein RM; Grimes WJ; Hersh EM
Cancer Res; 1995 Aug; 55(16):3584-91. PubMed ID: 7627967
[TBL] [Abstract][Full Text] [Related]
6. Tissue specificity of anti melanoma monoclonal antibodies analyzed on cell lines.
Johnson JP; Riethmüller G
Hybridoma; 1982; 1(4):381-5. PubMed ID: 6208134
[TBL] [Abstract][Full Text] [Related]
7. In vitro immunization of human B lymphocytes with cultured melanoma cells (SK-MEL 28).
Zhang XM; Borrebaeck CA
Hum Antibodies Hybridomas; 1990; 1(1):42-6. PubMed ID: 1966473
[TBL] [Abstract][Full Text] [Related]
8. Isolation and partial characterization of melanoma-associated antigens identified by autologous antibody.
Vlock DR; Scalise D; Meglin N; Kirkwood JM; Ballou B
J Clin Invest; 1988 Jun; 81(6):1746-51. PubMed ID: 3384949
[TBL] [Abstract][Full Text] [Related]
9. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA
Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926
[TBL] [Abstract][Full Text] [Related]
10. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
11. Tumor-reactive human immunoglobulin G monoclonal antibody from a melanoma patient.
Kan-Mitchell J; White WL; Mitchell MS
Cancer Res; 1989 Aug; 49(16):4536-41. PubMed ID: 2472881
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
Saxton RE; Mann BD; Morton DL; Burk MW
Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
[TBL] [Abstract][Full Text] [Related]
13. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition.
Pandolfi F; Boyle LA; Trentin L; Kurnick JT; Isselbacher KJ; Gattoni-Celli S
Cancer Res; 1991 Jun; 51(12):3164-70. PubMed ID: 1904004
[TBL] [Abstract][Full Text] [Related]
14. Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.
Bernhard H; Karbach J; Wölfel T; Busch P; Störkel S; Stöckle M; Wölfel C; Seliger B; Huber C; Meyer zum Büschenfelde KH
Int J Cancer; 1994 Dec; 59(6):837-42. PubMed ID: 7989126
[TBL] [Abstract][Full Text] [Related]
15. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.
Hom SS; Topalian SL; Simonis T; Mancini M; Rosenberg SA
J Immunother (1991); 1991 Jun; 10(3):153-64. PubMed ID: 1868040
[TBL] [Abstract][Full Text] [Related]
16. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody recognizing human melanoma-carcinoma cross-reacting oncofetal antigen epitopically associated with carcinoembryonic antigen.
Liao SK; Kwong PC; Clarke BJ; Dent PB; Ryan ED; Khosravi MJ; Laferte S; Krantz MJ
J Natl Cancer Inst; 1985 May; 74(5):1047-58. PubMed ID: 2582173
[TBL] [Abstract][Full Text] [Related]
18. Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody.
Real FX; Mattes MJ; Houghton AN; Oettgen HF; Lloyd KO; Old LJ
J Exp Med; 1984 Oct; 160(4):1219-33. PubMed ID: 6237165
[TBL] [Abstract][Full Text] [Related]
19. In vitro growth of B lymphocytes infiltrating human melanoma tissue by transformation with EBV: evidence for secretion of anti-melanoma antibodies by some transformed cells.
Watson DB; Burns GF; Mackay IR
J Immunol; 1983 May; 130(5):2442-7. PubMed ID: 6300247
[TBL] [Abstract][Full Text] [Related]
20. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
